Back

Identifying patients who benefit from the S3 protocol in ventricular tachycardia ablation

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Procedural workflows in ventricular arrhythmia ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Thomas Rosseel

Hospital Clinic, University of Barcelona, Barcelona (Spain)

5 More presentations in this session

Presentation thumbnail
Slow conduction zone isolation as a procedural endpoint in ventricular tachycardia ablation guided by multimodal substrate assessment
Doctor J. Acosta Martinez (Seville, ES)
Abstract Slides Video
Presentation thumbnail
Feasibility and safety of strategic multielectrode positioning guided by S3 protocol for hemodynamically unstable ventricular tachycardia: the S3-STaMP project
Doctor R. Pittorru (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Functional substrate versus anatomical ablation approaches in structural ventricular tachycardia, in-silico comparison with a novel digital twin framework
Doctor M. Parollo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Accuracy of modified multipolar voltage map thresholds in identifying slow conduction channels for VT ablation: challenging the concept of dense scar
Doctor L. Gigli (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Wall thickness channels and lipomatous metaplasia assessed by cardiac computed tomography hypoenhancement as a predictors of deceleration zones in ventricular tachycardia ablation
Doctor P. Rodriguez Fraga (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Procedural workflows in ventricular arrhythmia ablation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Temporal dynamics of deceleration zones during S3 isochronal mapping-guided VT ablation
thumbnail
Congress Presentation
Efficacy and outcomes of S3 functional mapping for VT ablation in non-ischaemic cardiomyopathy
thumbnail
Congress Presentation
Safety and hemodynamic stability during s3 functional substrate mapping in ventricular tachycardia ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources